These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 23255823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A.
    Neurology; 2005 Feb 08; 64(3):536-8. PubMed ID: 15699390
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI, Ströbel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A.
    Ann Neurol; 2005 Mar 08; 57(3):444-8. PubMed ID: 15732104
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
    Zhou L, McConville J, Chaudhry V, Adams RN, Skolasky RL, Vincent A, Drachman DB.
    Muscle Nerve; 2004 Jul 08; 30(1):55-60. PubMed ID: 15221879
    [Abstract] [Full Text] [Related]

  • 11. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
    Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ.
    J Autoimmun; 2014 Aug 08; 52():139-45. PubMed ID: 24373505
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different characteristic phenotypes according to antibody in myasthenia gravis.
    Oh SJ, Morgan MB, Lu L, Hatanaka Y, Hemmi S, Young A, Claussen GC.
    J Clin Neuromuscul Dis; 2012 Dec 08; 14(2):57-65. PubMed ID: 23172384
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A.
    Nat Med; 2001 Mar 08; 7(3):365-8. PubMed ID: 11231638
    [Abstract] [Full Text] [Related]

  • 18. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
    Aubert S, Salort-Campana E, Franques J, Uzenot D, Pouget J.
    Rev Neurol (Paris); 2009 Nov 08; 165(11):901-10. PubMed ID: 19327804
    [Abstract] [Full Text] [Related]

  • 19. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R, Motomura M, Masuda T, Shiraishi H, Tokuda M, Fukuda T, Ando T, Yoshimura T, Tsujihata M, Kawakami A.
    Eur J Neurol; 2013 Sep 08; 20(9):1272-6. PubMed ID: 23679930
    [Abstract] [Full Text] [Related]

  • 20. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A, Leite MI.
    Curr Opin Neurol; 2005 Oct 08; 18(5):519-25. PubMed ID: 16155434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.